UK Core Clinical and Technical Assurance Sprint 8 Documentation Pack

Please note:

This Documentation Pack for Clinical and Technical Assurance Sprint 8 is for review purposes.
Please follow the guidance on the "Contact Us" page if you need any assistance.

Please note:

This is a 'technical sprint'. The scope of this sprint only includes improvements and fixes. New FHIR assets are out of scope for this sprint.
The menu links for 'Use Cases', 'FHIR Assets' and 'Version Comparison' have been removed in this Documentation Pack.

Issue 17

Context of Issue
Context:	UKCore-BloodPressure-Systolic (ValueSet)
Type:	Terminology Concepts
Source:	Simplifier Issue
Scope:	Proposed In Scope

Issue	Proposal
Concepts to use when recording central venous pressure. Currently if you are representing a CVP or other invasive blood pressures, which appear to be in scope, there are no appropriate concepts to record the systolic and diasolic pressures. It would not be correct to use 271649006 \| Systolic blood pressure (observable entity) as this is not what it is. So to represent correctly you would need to use a concept specifically for invasive blood pressure.	Propose to use a concept such as 276776003 \|Right atrial pressure - a wave (observable entity) \| or 276772001 \|Right ventricular systolic pressure (observable entity)\|. This would need validating with clinical experts.

Issue

Proposal

Concepts to use when recording central venous pressure. Currently if you are representing a CVP or other invasive blood pressures, which appear to be in scope, there are no appropriate concepts to record the systolic and diasolic pressures. It would not be correct to use 271649006 | Systolic blood pressure (observable entity) as this is not what it is. So to represent correctly you would need to use a concept specifically for invasive blood pressure.

Propose to use a concept such as 276776003 |Right atrial pressure - a wave (observable entity) | or 276772001 |Right ventricular systolic pressure (observable entity)|. This would need validating with clinical experts.